ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 (Topo 1) ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating payloads, today announced that the Company will ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

Scientists have discovered a defensive method of cells that resembles Spiderman shooting his web to ensnare enemies. These ...

Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

RNA modifications have emerged as a crucial area of research within molecular viral pathogenesis, providing new insights into how viruses hijack host gene ...